Skip to main content
. Author manuscript; available in PMC: 2016 Sep 15.
Published in final edited form as: Oncogene. 2012 Jun 11;32(17):2131–2139. doi: 10.1038/onc.2012.239

Table 1.

Cytoplasmic Dicer staining and clinicopathologic characteristics of 262 cases of primary melanomas

Cytoplasmic Dicer staining
Total p value*
Negative Weak Strong
Age
 ≤62 15 (11.2%) 31 (23.1%) 88 (65.7%) 134 0.702
 >62 15 (11.7%) 35 (27.3%) 78 (61.0%) 128
Sex
 Male 23 (16.7%) 32 (23.2%) 83 (60.1%) 138 0.009
 Female 6 (4.8%) 35 (28.2%) 83 (67.0%) 124
Tumor thickness (mm)
 ≤2 mm 12 (8.2%) 34 (23.1%) 101 (68.7%) 147 0.073
 >2mm 18 (15.7%) 32 (27.8%) 65 (56.5%) 115
Ulceration
 Present 8 (14.8%) 14 (25.9%) 32 (59.3%) 54 0.648
 Absent 22 (10.6%) 52 (25.0%) 134 (64.4%) 208
Lymphocytic response
 Present 12 (12.8%) 15 (15.9%) 67 (71.3%) 94 0.036
 Absent 18 (10.7%) 51 (30.4%) 99 (58.9%) 168
Tumor subtype
 Lentigo maligna 10 (21.3%) 9 (19.1%) 28 (59.6%) 47 0.256
 Superficial spreading 8 (8.8%) 24 (26.4%) 59 (64.8%) 91
 Nodular 5 (10.9%) 9 (19.6%) 32 (69.5%) 46
 Other 7 (9.0%) 24 (30.8%) 47 (60.2%) 78
Site
 Sun-exposed 13 (13.8%) 22 (23.4%) 59 (62.8%) 94 0.632
 Sun-protected 17 (10.1%) 44 (26.2%) 107 (63.7%) 168
*

χ2 test.

Other: unspecified subtype.

Sun-protected sites: trunk, arm, leg and feet; Sun-exposed sites: head and neck.